Rhythm Pharmaceuticals
Price & Volume
Stats
See more52W Range | $21.34-$55.64 |
Market Cap | $3B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $101.7M |
Revenue Growth (YoY) | 51.3% |
Gross Profit (12 Mos) | $21.5M |
Diluted EPS | -$4.35 |
News
See moreYahoo Finance • 14 days ago
Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish
Yahoo Finance • 18 days ago
RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc
Yahoo Finance • 4 months ago
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
Yahoo Finance • 5 months ago
Jim Cramer Portfolio: 11 Latest Stocks to Buy
About
CEO | Dr. David P. Meeker M.D. |
CFO | Mr. Hunter C. Smith M.B.A. |
Address | 222 Berkeley Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 226 |
